Dun & Bradstreet
Interview featuring Manish Soman, President and CEO, Sciformix Corporation
Q)Kindly share with us the genesis and journey of Sciformix Technologies.
A) Sciformix Corporation is a global service provider for the biopharmaceutical, generic pharmaceutical, consumer product, medical device and contract research industries. Ajit Nagral, founder & Chairman, and Chitra Lele, co-founder and Chief Scientific Officer, had the vision of establishing a company to provide specialized science based services to pharmaceutical organizations.
Our Safety & Risk Management and Biometrics offerings progressively expanded to include Medical Writing and Regulatory Affairs to support our clients’ growing needs. Subsequently we expanded our Clinical Research and Post Approval Support Services to include clinical trial conduct and have recently added Technology services to our list of offerings. Sciformix has created a global cost and resource-optimized business model, affording us the flexibility and scalability to tap into a worldwide pool of talent with a diverse skill-set.
The company employs ~1,000 employees around the world and is acclaimed for its depth of scientific expertise and technology capabilities. Sciformix is headquartered in the Unites States with delivery centers in the UK, India and Philippines.